Will A Proposed Rule For Additional Cannabis Research Lift The Four-Year Pause By The Department Of Justice?

The U.S. DEA recently proposed a rule for granting additional cultivation licenses for research-grade cannabis. Currently, only the University of Mississippi holds a license. If this rule comes into effect, it would be the end of the 4-year pause by the Department of Justice. Under this new rule, the DEA will have the sole ownership of all the cannabis produced under this license. The agency has already started reviewing 35 institutions who have submitted for a license.

The applicants are grouped into three license types: growers or bulk manufacturers of cannabis that would conduct their own research; growers that would supply DEA-registered researchers with cannabis; and growers that would supply the Drug Supply Program of NIDA.

This rule follows on a report made to the Congress by the FDA, charting out a higher interest in drug development from cannabidiol. This report talked about the FDA activities to promote research on CBD while also encouraging researchers to share new data with the agency. On March 11, 2020, the FDA reopened a public docket when the interest around the subject grew.

Read Full Article: https://www.jdsupra.com

CBD is one of many powerful cannabinoids found in hemp known for helping to support our body and mind. Here at Healing Dragon CBD we do not intend to make unfounded medical claims about the health benefits of CBD. The FDA has not confirmed that CBD cures, treats, or prevents any diseases or conditions. Before reading this article please take a moment to read our full disclosure statement.